On the other hand, FH-inactivated HLRCC also demonstrates the fumarate accumulation-related attenuation of NRF2 degradation (54), which is the notable protective factor in the inhibition of ferroptosis (30, 55, 56). Here, FH is linked to hereditary leiomyomatosis and renal cell cancer.